Home › Funds › Royce & Associates › DORM

Royce & Associates position in DORM

DORMAN PRODUCTS INC · Consumer Discretionary

Royce & Associates reported holding 753,771 shares of DORM (DORMAN PRODUCTS INC) in its Q3 2026 13F filing — a position valued at US$92.4M, representing 0.84% of its reported portfolio and ranking #6 among its reported holdings. Royce & Associates has disclosed DORM holdings in 21 of the last 21 reported quarters, going back to Q3 2021.

Latest position (Q3 2026)753.77K sh
Reported value held$92.41M
Portfolio Weight0.84%
First reportedQ3 2021
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Royce & Associates's DORM position evolved

Royce & Associates first disclosed a stake in DORM in Q3 2021 at 491,584 shares (US$46.5M). The position peaked in Q2 2026 at 824,216 shares, worth US$112.5M. Across 21 filings, Royce & Associates increased the stake 11 time(s), trimmed it 8 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 753,771 shares valued at US$92.4M — a reduction of -70,445 shares quarter over quarter.. Notable position changes include a 34% increase in Q2 2026 (shares fell 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2021 491.58K $46.54M New
Q4 2021 520.05K $58.77M Add
Q1 2022 563.84K $53.58M Add
Q2 2022 653.93K $71.74M Add
Q3 2022 683.84K $56.16M Add
Q4 2022 597.71K $48.34K Reduce
Q1 2023 613.01K $52.88K Add
Q2 2023 633.20K $49.92M Add
Q3 2023 628.51K $47.62M Reduce
Q4 2023 527.83K $44.03M Reduce
Q1 2024 455.05K $43.86M Reduce
Q2 2024 445.39K $40.74M Reduce
Q3 2024 523.88K $59.26M Add
Q4 2024 509.95K $66.06M Reduce
Q1 2025 486.79K $58.68M Reduce
Q2 2025 493.33K $60.52M Add
Q3 2025 497.42K $77.54M Add
Q4 2025 498.96K $61.47M Hold
Q1 2026 616.66K $64.35M Add
Q2 2026 824.22K $112.46M Add
Q3 2026 753.77K $92.41M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DORM and 13F data

DORM (DORMAN PRODUCTS INC) is a Consumer Discretionary company. 31 other funds we track also report a position in DORM — the largest reported positions include KTF INVESTMENTS, LLC (US$106.5M), ROYCE & ASSOCIATES LP (US$92.4M), REINHART PARTNERS, LLC. (US$85.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DORM

All DORM fund holders →

FAQ

How long has Royce & Associates held DORM?

Royce & Associates has disclosed DORM holdings in 21 of the last 21 reported quarters, going back to Q3 2021.

What is Royce & Associates's current position in DORM?

As of Q3 2026, Royce & Associates holds 753.77K shares of DORM (DORMAN PRODUCTS INC), valued at $92.41M, representing 0.84% of its reported portfolio and ranking #6.

Has Royce & Associates been buying or selling DORM?

In the latest 13F filing (Q3 2026), Royce & Associates reduced its position in DORM. The position peaked in Q2 2026 at 824.22K shares.

Which other funds hold DORM?

Other major institutional holders of DORM include KTF INVESTMENTS, LLC, ROYCE & ASSOCIATES LP, REINHART PARTNERS, LLC., among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.